Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-04-18 @ 7:17 AM
Study NCT ID:
NCT02723994
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-17
First Post:
2016-03-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-09
First Submit QC Date:
None
Study First Post Date:
2016-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-15
Last Update Post Date:
2025-10-17
Last Update Post Date Type:
ESTIMATED